15 Frequently Asked Questions : Bone Marrow Transplant Treatment in India for Bangladeshi Patients

Q1 · What is Bone Marrow Transplant Treatment?

A bone marrow transplant replaces or supports damaged or diseased blood-forming stem cells with healthy hematopoietic stem cells.

These stem cells can develop into

• Red blood cells
• White blood cells
• Platelets
• Other blood-forming cells

The transplant process may be used after intensive treatment has eliminated or suppressed diseased bone-marrow cells.

Main Types of Bone Marrow Transplant

1. Autologous Stem Cell Transplant

The patient's own stem cells are collected before intensive treatment and then returned after conditioning therapy.

This approach may be used for selected conditions such as certain

• Lymphomas
• Multiple myeloma
• Other diseases where autologous transplantation is appropriate

2. Allogeneic Stem Cell Transplant

Stem cells come from another person who is considered a suitable donor.

The donor may be

• A matched sibling
• Another related donor
• A matched unrelated donor
• A haploidentical donor
• Another appropriately selected donor

3. Paediatric Bone Marrow Transplant

Children with certain blood cancers, inherited disorders or immune deficiencies may undergo specialized transplantation.

4. Haploidentical Transplant

A partially matched family donor may be considered for selected patients when an appropriate fully matched donor is unavailable.

The choice of transplant depends on the disease, remission status, patient age, general health, donor availability and transplant-centre assessment.

Q2 · How much does Bone Marrow Transplant Treatment cost in Bangladesh compared with India?

The cost of bone marrow transplantation varies substantially depending on the type of transplant, disease, conditioning treatment, donor requirements, stem-cell source, hospitalization, complications and supportive care.

For planning purposes, this guide uses

• US$1 ≈ BDT 122
• US$1 ≈ INR 96

Indicative Cost Comparison

These are indicative planning ranges only and are not fixed quotations. Actual costs may vary considerably according to diagnosis, transplant type, donor matching, conditioning regimen, stem-cell collection, medicines, blood products, ICU requirements, infections, graft-versus-host disease, hospitalization and other complications. Potential savings are not guaranteed.

Patients should ask whether the quotation includes

• Initial consultation
• Complete transplant evaluation
• Bone-marrow examination
• HLA typing
• Donor evaluation
• Stem-cell collection
• Conditioning therapy
• Transplant procedure
• Chemotherapy
• Blood products
• Antimicrobial medicines
• Immunosuppressive medicines
• ICU charges
• Isolation-room charges
• Hospital stay
• Laboratory testing
• Imaging
• Pathology
• Management of complications
• Follow-up consultations

Patients should obtain a detailed written quotation and specifically clarify whether donor testing, stem-cell collection, medicines and management of complications are included.

Q3 · Which Indian cities can Bangladeshi patients consider for Bone Marrow Transplant Treatment?

Patients should confirm that the selected centre provides the specific transplant type required and has appropriate isolation facilities, transplant ICU support, blood-bank services, infectious-disease support and long-term follow-up.

Q4 · Which hospitals in India can Bangladeshi patients consider for Bone Marrow Transplant Treatment?

Patients should confirm the current availability of a dedicated bone-marrow or hematopoietic stem-cell transplant programme before making travel arrangements.

Q5 · What types of Bone Marrow Transplant Treatment are available in India?

1. Autologous Stem Cell Transplant

The patient's own stem cells are collected, stored and returned after high-dose treatment.

2. Allogeneic Stem Cell Transplant

Stem cells are obtained from another suitable donor.

3. Matched-Sibling Transplant

A brother or sister with appropriate HLA compatibility may be considered as a donor.

4. Matched-Related Donor Transplant

Another suitable family donor may be considered depending on compatibility and transplant assessment.

5. Matched-Unrelated Donor Transplant

A donor outside the immediate family may be identified through appropriate donor registries and matching processes.

6. Haploidentical Transplant

A partially matched family donor may be used in selected cases.

7. Paediatric Stem Cell Transplant

Children with selected cancers, inherited blood disorders, immune deficiencies and other conditions may require specialized transplantation.

8. Transplant for Blood Cancers

HSCT may be considered in selected patients with

• Acute leukemia
• Certain lymphomas
• Multiple myeloma
• Myelodysplastic syndromes
• Other hematologic malignancies

9. Transplant for Non-Malignant Disorders

Selected patients with disorders such as

• Thalassemia
• Aplastic anemia
• Sickle-cell disease
• Certain immune deficiencies
• Selected inherited metabolic disorders

may be evaluated for transplantation. The appropriate transplant type depends on the individual diagnosis and specialist assessment.

Q6 · Who may be suitable for Bone Marrow Transplant Treatment?

A transplant may be considered for selected patients with serious blood, bone-marrow, immune or inherited disorders.

Possible indications include

• Acute leukemia
• Selected chronic leukemias
• Lymphoma
• Multiple myeloma
• Myelodysplastic syndromes
• Aplastic anemia
• Thalassemia
• Sickle-cell disease
• Certain inherited immune disorders
• Selected inherited metabolic diseases
• Other conditions where HSCT may provide an appropriate treatment option

The transplant team considers

• Age
• Diagnosis
• Disease stage
• Disease response to treatment
• Remission status
• General health
• Organ function
• Infection status
• Donor availability
• HLA compatibility

Not every patient with a blood disorder requires transplantation.

Q7 · What tests are required before Bone Marrow Transplant Treatment?

Pre-transplant evaluation can be extensive.

Patient Assessment

Possible investigations include

• Complete blood count
• Bone-marrow aspiration
• Bone-marrow biopsy
• Flow cytometry
• Cytogenetic testing
• Molecular testing
• Disease-specific genetic tests
• Blood-group testing
• HLA typing
• Viral screening
• Infection screening
• Liver-function tests
• Kidney-function tests
• Electrolytes
• ECG
• Echocardiography
• Chest imaging
• Pulmonary-function testing
• Dental evaluation
• Nutritional assessment

Donor Assessment

A potential donor may undergo

• HLA typing
• Blood-group testing
• Infectious-disease screening
• Complete blood count
• General health assessment
• Medical history
• Additional investigations required for stem-cell donation

The final testing plan depends on the disease and transplant protocol.

Q8 · What medical records should Bangladeshi patients send before travelling?

Patients should provide as many relevant records as possible, including

• Complete blood-count reports
• Bone-marrow biopsy reports
• Bone-marrow aspiration reports
• Flow-cytometry reports
• Cytogenetic reports
• Molecular or genetic test results
• Pathology reports
• Disease-staging reports
• Previous chemotherapy records
• Previous radiotherapy records
• Previous hospital discharge summaries
• Blood-transfusion history
• Infection history
• Current medication list
• Blood-group report
• HLA report, if available
• Donor HLA report, if available
• CT / PET-CT reports where relevant
• MRI reports where relevant
• Recent kidney and liver-function tests

Patients should also provide a concise treatment history covering

• Date of diagnosis
• Previous treatments
• Response to treatment
• Current disease status
• Previous complications
• Current symptoms
• Current medications

If a potential donor is available, the donor's available medical and HLA records should also be provided.

Q9 · How does Bone Marrow Transplant Treatment work?

The treatment process generally involves several stages.

Step 1: Transplant Evaluation

The hematology and transplant team confirms the diagnosis and determines whether transplantation is appropriate.

Step 2: Donor Identification

For an allogeneic transplant, an appropriate donor is identified based on HLA compatibility and other clinical factors.

Step 3: Stem-Cell Collection

Stem cells may be collected from

• Peripheral blood
• Bone marrow
• Umbilical cord blood in selected circumstances

Step 4: Conditioning Treatment

The patient receives chemotherapy, with or without radiotherapy, to prepare the body for transplantation.

The conditioning regimen depends on the disease and transplant type.

Step 5: Stem-Cell Infusion

The collected stem cells are infused into the patient through an intravenous line.

The process is generally similar to an intravenous infusion rather than a conventional surgical operation.

Step 6: Engraftment

The transplanted stem cells begin producing new blood cells.

During this period, patients may have very low blood-cell counts and require intensive monitoring and supportive treatment.

Step 7: Infection Prevention and Supportive Care

Treatment may include

• Antibiotics when required
• Antiviral medicines
• Antifungal medicines
• Blood and platelet transfusions
• Nutritional support
• Close laboratory monitoring

Step 8: Long-Term Follow-Up

Allogeneic transplant recipients may require monitoring for

• Graft-versus-host disease
• Infection
• Rejection or graft failure
• Organ complications
• Disease relapse
• Medication-related complications

Q10 · What are the alternatives to Bone Marrow Transplant Treatment?

A bone marrow transplant is not necessary or appropriate for every patient.

Depending on the disease, alternatives may include

• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation therapy
• Maintenance treatment
• Supportive care
• Blood transfusions
• Growth-factor treatment
• Iron-chelation treatment for selected patients
• Disease-specific medicines
• Cellular therapies in selected conditions

For some blood cancers, modern targeted or immune-based treatments may be used before transplantation or instead of transplantation. The appropriate treatment depends on the diagnosis, genetic characteristics, disease response and overall health.

Q11 · What should Bangladeshi patients ask before accepting a Bone Marrow Transplant quotation?

Patients and families should ask

• What is the exact diagnosis?
• Is transplantation necessary for this condition?
• What type of transplant is being recommended?
• Is the transplant autologous or allogeneic?
• Is a suitable donor available?
• What is the patient's HLA status?
• What is the donor's HLA status?
• Is haploidentical transplantation being considered?
• What conditioning regimen will be used?
• How long will conditioning take?
• How will stem cells be collected?
• Is stem-cell collection included in the quotation?
• Are donor-related expenses included?
• Are chemotherapy medicines included?
• Are blood and platelet transfusions included?
• Is isolation-room hospitalization included?
• Are ICU charges included?
• Are antimicrobial medicines included?
• What complications could increase the cost?
• What is the expected hospital stay?
• How long should the patient remain in India after discharge?
• What is the risk of graft-versus-host disease?
• What long-term medicines may be required?
• How will follow-up be managed in Bangladesh?
• What expenses are excluded from the quotation?

Patients should request an itemized written quotation before travelling.

Q12 · How long should Bangladeshi patients stay in India for Bone Marrow Transplant Treatment?

The overall stay can be considerably longer than that required for routine surgery.

It may include

• Initial specialist evaluation
• Additional investigations
• Donor evaluation
• Conditioning therapy
• Stem-cell transplantation
• Engraftment monitoring
• Management of complications
• Early post-transplant follow-up

The hospital stay may extend for several weeks, particularly for allogeneic transplantation.

The actual duration depends on

• Transplant type
• Disease
• Conditioning regimen
• Blood-count recovery
• Infection
• Graft-versus-host disease
• Organ function
• Other complications

Patients should plan accommodation and finances for a potentially extended stay in India. They should not arrange early return travel until the treating team confirms that the patient is medically stable for travel.

Q13 · What is recovery like after Bone Marrow Transplant Treatment?

Recovery after transplantation is gradual and can continue for months.

During the early period, patients may experience

• Fatigue
• Weakness
• Reduced blood counts
• Nausea
• Appetite changes
• Mouth sores
• Increased infection risk
• Temporary hair loss
• Digestive symptoms

Patients may require

• Blood transfusions
• Platelet transfusions
• Antibiotics
• Antiviral treatment
• Antifungal treatment
• Nutritional support
• Regular blood tests

After Allogeneic Transplant

Some patients may develop graft-versus-host disease, in which donor immune cells react against the recipient's tissues.

It can affect areas such as

• Skin
• Liver
• Gastrointestinal tract

The transplant team monitors closely for this and other complications.

Long-Term Recovery

Patients may require

• Regular blood testing
• Medication monitoring
• Infection prevention
• Vaccination planning
• Nutritional support
• Gradual physical rehabilitation
• Disease surveillance

The immune system may take a substantial amount of time to recover after transplantation.

Q14 · How can follow-up be managed after returning to Bangladesh?

Before leaving India, patients should obtain

• Complete discharge summary
• Transplant report
• Conditioning-treatment summary
• Stem-cell source and transplant details
• Donor information where appropriate
• Recent blood-test results
• Pathology reports
• Molecular or genetic reports
• Medication list
• Immunosuppressive medication schedule, where applicable
• Infection-prevention instructions
• Follow-up schedule

The patient should arrange ongoing follow-up with a hematologist or transplant specialist in Bangladesh.

Follow-up may include

• Complete blood count
• Liver-function tests
• Kidney-function tests
• Drug-level monitoring
• Infection testing
• Bone-marrow assessment where required
• Disease-monitoring tests
• Assessment for graft-versus-host disease
• Imaging when clinically indicated

Patients should seek prompt medical attention for symptoms such as

• Fever
• Persistent vomiting
• Severe diarrhoea
• New skin rash
• Jaundice
• Breathing difficulty
• Unusual bleeding
• Severe weakness
• Persistent mouth ulcers
• New or worsening symptoms

Patients should not stop immunosuppressive medicines without specialist guidance.

Q15 · Should a Bangladeshi patient travel to India for Bone Marrow Transplant Treatment?

The decision should be based on the patient's diagnosis, transplant indication, donor availability, treatment plan, expected duration of stay and long-term follow-up requirements.

Before travelling, patients should consider

• Exact diagnosis
• Current disease status
• Previous treatment response
• Recommended transplant type
• Donor availability
• HLA compatibility
• Conditioning regimen
• Expected hospitalization
• Potential complications
• Long-term medication requirements
• Follow-up requirements
• Total estimated treatment cost
• Financial planning for complications or extended hospitalization
• Follow-up arrangements in Bangladesh

Patients should ideally obtain a preliminary transplant opinion after sharing complete medical records and available donor information before making travel arrangements.